Search results
Results From The WOW.Com Content Network
Along with the £12m gap in government funding offers - equivalent to just over 2.5 per cent of the entire £450m deal - AstraZeneca cited “timing” as another reason for rejecting the deal.
She named AstraZeneca in her speech as an example of one of the "great companies" that was investing in the UK. The project would have seen an expansion of its vaccine manufacturing plant in Speke ...
AstraZeneca has cancelled a planned £450 million investment in a vaccine manufacturing plant in Merseyside, saying Labour failed to match the previous government’s offer of support.
One example is the initiation fee, a fee charged by the union to the worker when the employee first joins the union. The initiation fee covers the administrative costs of joining the union. Fees may, however, be ongoing. For example, a union program (such as a welfare or benefit fund) may be offered only to those union members who pay a regular ...
A packet of AstraZeneca COVID-19 vaccine vials. A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, [1] and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol.
In February 2021, the situation in the European Union due to the pandemic was worsening, as the lockdown continued, people kept dying, and the union's biggest vaccine supplier, AstraZeneca, was having production problems, which caused a shortage of doses.
The previous offer included up to 70 million in grants to develop a facility in Speke, Liverpool and 20 million pounds in research and development support from the UK Health Security Agency, the ...
On 31 August, AstraZeneca announced that it had begun enrolment of adults for a US-funded, 30,000-subject late-stage study. [105] Clinical trials for the vaccine candidate were halted worldwide on 8 September, as AstraZeneca investigated a possible adverse reaction which occurred in a trial participant in the UK.